<?xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.7.2-ppt DokuWiki" -->
<?xml-stylesheet href="http://www.finovi.org/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="http://www.finovi.org/feed.php">
        <title>Finovi en</title>
        <description></description>
        <link>http://www.finovi.org/</link>
        <image rdf:resource="http://www.finovi.org/lib/images/favicon.ico" />
       <dc:date>2023-01-22T12:22:23+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="http://www.finovi.org/en:finovi?rev=1236680351&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:mentions_legales?rev=1229101332&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:pratique?rev=1329729719&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:presse?rev=1229019344&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:publications?rev=1232379427&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:realisations?rev=1232379442&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:recherche?rev=1236681243&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:soutenir?rev=1229349520&amp;do=diff"/>
                <rdf:li rdf:resource="http://www.finovi.org/en:start?rev=1646299829&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="http://www.finovi.org/lib/images/favicon.ico">
        <title>Finovi</title>
        <link>http://www.finovi.org/</link>
        <url>http://www.finovi.org/lib/images/favicon.ico</url>
    </image>
    <item rdf:about="http://www.finovi.org/en:finovi?rev=1236680351&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2009-03-10T10:19:11+00:00</dc:date>
        <title>Presentation</title>
        <link>http://www.finovi.org/en:finovi?rev=1236680351&amp;do=diff</link>
        <description>The FINOVI foundation supports infectious diseases research, in particular hepatitis, respiratory diseases and nosocomial infections. Its goal is to contribute to develop new therapeutic and preventive solutions against infectious diseases. 
The foundation is aiming at structuring cutting edge and innovative research in the infectious diseases field in the Lyon-Grenoble area.</description>
    </item>
    <item rdf:about="http://www.finovi.org/en:mentions_legales?rev=1229101332&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2008-12-12T17:02:12+00:00</dc:date>
        <title>Mentions légales</title>
        <link>http://www.finovi.org/en:mentions_legales?rev=1229101332&amp;do=diff</link>
        <description>Editeur du site

Fondation FINOVI 

50, avenue Tony Garnier 

69007 LYON 



	*  Directeur de la publication : Christelle BIDAUD / Jean-Pierre GORVEL
		*   Créateur du site : Ce site a été crée par la société DDB et Colin LORRAIN
		*   Crédits Photos : DDB
		*   Hébergeur :  Colin LORRAIN</description>
    </item>
    <item rdf:about="http://www.finovi.org/en:pratique?rev=1329729719&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2012-02-20T09:21:59+00:00</dc:date>
        <title>Contact</title>
        <link>http://www.finovi.org/en:pratique?rev=1329729719&amp;do=diff</link>
        <description>To contact us: &lt;info@finovi.org&gt;

L'équipe

	*  Michel Van der Rest – Executive Director 
 04 37 70 10 10 - &lt;michel.vanderrest@finovi.org&gt;

	*  Jocelyne Reynard – Assistant 
 04 37 70 10 10 - &lt;jocelyne.reynard@finovi.org&gt;

Visit us at the FINOVI foundation

Fondation FINOVI 

Bâtiment Domilyon - 321, avenue Jean Jaurès

69007 LYON 

Tel : +33 (0)4 37 70 10 10 – Fax : +33 (0)4 72 70 48 29</description>
    </item>
    <item rdf:about="http://www.finovi.org/en:presse?rev=1229019344&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2008-12-11T18:15:44+00:00</dc:date>
        <title>Espace presse</title>
        <link>http://www.finovi.org/en:presse?rev=1229019344&amp;do=diff</link>
        <description></description>
    </item>
    <item rdf:about="http://www.finovi.org/en:publications?rev=1232379427&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2009-01-19T15:37:07+00:00</dc:date>
        <title>Publications</title>
        <link>http://www.finovi.org/en:publications?rev=1232379427&amp;do=diff</link>
        <description>Nothing for now.</description>
    </item>
    <item rdf:about="http://www.finovi.org/en:realisations?rev=1232379442&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2009-01-19T15:37:22+00:00</dc:date>
        <title>Projects supported</title>
        <link>http://www.finovi.org/en:realisations?rev=1232379442&amp;do=diff</link>
        <description>*  Projects financed
	*  Recruitment
	*  Publications</description>
    </item>
    <item rdf:about="http://www.finovi.org/en:recherche?rev=1236681243&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2009-03-10T10:34:03+00:00</dc:date>
        <title>Research</title>
        <link>http://www.finovi.org/en:recherche?rev=1236681243&amp;do=diff</link>
        <description>Infectious diseases - diseases caused by the transmission of micro-organisms such as viruses, bacteria, parasites, fungal infections and prions - are a threat to inhabitants of industrialized nations and developing nations alike.

Researchers estimate that, of the 50 to 60 million people dying worldwide, nearly one‑third are lost to infectious diseases. Consequently, it is no surprise that infectology - the science of understanding infections - has become a subject of critical importance, and th…</description>
    </item>
    <item rdf:about="http://www.finovi.org/en:soutenir?rev=1229349520&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2008-12-15T13:58:40+00:00</dc:date>
        <title>Investors/Contributors</title>
        <link>http://www.finovi.org/en:soutenir?rev=1229349520&amp;do=diff</link>
        <description>Which tax benefits for the contributors?

Individuals

Income tax deduction

Donations to qualified charitable foundations entitle individuals to an income tax deduction equal to 66% of the contribution total amount, The deduction limit being 20% of taxable income (art. 200 du CGI (tax code)).</description>
    </item>
    <item rdf:about="http://www.finovi.org/en:start?rev=1646299829&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2022-03-03T09:30:29+00:00</dc:date>
        <title>A WORD FROM THE CHAIRMAN</title>
        <link>http://www.finovi.org/en:start?rev=1646299829&amp;do=diff</link>
        <description>For the current calls for proposals, Please refer to the French version.




Infectious diseases are a critically important factor in public health and French academic research relies upon the provision of sufficient resources.

For these reasons, we support Infectology research focused on the skills centre already established in Lyon and Grenoble.

This will ensure that, in the future, we will have improved treatments in such areas as hepatitis, tuberculosis and nosocomial diseases, among other…</description>
    </item>
</rdf:RDF>
